The problem

Enzymes are key to unlocking the radical transformation of the chemical manufacturing industry as they look to become cleaner, more renewable, and less carbon intensive. 

They are the backbone of numerous bio-industrial solutions, in manufacturing and chemistry (bio-based chemicals and bio-plastics), agriculture (production of biopesticides and biofertilisers), and pharmaceuticals (drug production), to name a few. 

The problem is that enzymes are often slow and inefficient. Traditional methods for discovering and improving enzymes are time-consuming, costly, and limited in throughput and data collection. This is causing a huge bottleneck in industries that rely on enzyme-based biological processes. 

To usher in the next industrial revolution, we need efficient biosolutions: and to do this, we need radically more efficient enzymes.

The solution

Enzidia aims to dramatically accelerate enzyme optimisation, paving the way for faster, more efficient, and more sustainable industrial bioprocesses.

Enzidia’s platform addresses the common bottleneck of enzyme efficiency by significantly increasing the capacity to screen and collect data on enzyme variants. This allows them to identify and engineer faster, more effective enzymes with an unprecedented rate, thereby enabling more competitive and eco-friendly bioprocesses.

At the centre of the business is the Enzidia Evolutionary Wheel, aimed at unblocking the two key bottlenecks around enzyme engineering: screening throughput and data size. The former is a numbers game – the more you screen, the more likely you are to find a faster enzyme; the latter is around collecting more information to inform, through AI-based learning, what constitutes better enzyme sequences. 

On screening throughput, the ENZIDIA platform has a library creation and screening capacity that is 3 orders of magnitude greater than state-of-the-art, and 7 orders of magnitude greater than robotics-based platforms. In terms of data collection, their patent-pending technology MillionFull allows an unprecedented capacity, giving their use of AI a fundamental advantage.

Why we’re excited to invest

Marian Gazdik, partner at G-Force: “Jinbei, Enzidia’s founder, is clearly mission driven and unapologetically ambitious with his unique approach of making the enzymes industry orders of magnitude more efficient. Enzidia isn’t just shaping the future—it’s accelerating it. This is exactly the kind of disruptive innovation we love to invest in and help scale.”